Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis Posted on August 2, 2022September 23, 2022 by Viken Doudzdjian
The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies Posted on November 4, 2021January 10, 2022 by admin
Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High Frequency Nerve Block System Posted on June 29, 2021January 10, 2022 by admin
